Global Group B Streptococcus (GBS) Infection Treatment Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Group B Streptococcus (GBS) Infection Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Group B Streptococcus (GBS) Infection Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Group B Streptococcus (GBS) Infection Treatment market in any manner.
Global Group B Streptococcus (GBS) Infection Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer Inc.
Alopexx Enterprises, LLC
Wellstat Vaccines LLC
Minervax ApS
Novartis
GlaxoSmithKline
Market Segmentation (by Type)
Prenatal-onset Gbs Disease
Early-onset Gbs Disease
Late-onset Gbs Disease
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Group B Streptococcus (GBS) Infection Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Group B Streptococcus (GBS) Infection Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Group B Streptococcus (GBS) Infection Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Group B Streptococcus (GBS) Infection Treatment market in any manner.
Global Group B Streptococcus (GBS) Infection Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer Inc.
Alopexx Enterprises, LLC
Wellstat Vaccines LLC
Minervax ApS
Novartis
GlaxoSmithKline
Market Segmentation (by Type)
Prenatal-onset Gbs Disease
Early-onset Gbs Disease
Late-onset Gbs Disease
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Group B Streptococcus (GBS) Infection Treatment Market
- Overview of the regional outlook of the Group B Streptococcus (GBS) Infection Treatment Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Group B Streptococcus (GBS) Infection Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Group B Streptococcus (GBS) Infection Treatment
1.2 Key Market Segments
1.2.1 Group B Streptococcus (GBS) Infection Treatment Segment by Type
1.2.2 Group B Streptococcus (GBS) Infection Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Group B Streptococcus (GBS) Infection Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Group B Streptococcus (GBS) Infection Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Group B Streptococcus (GBS) Infection Treatment Sales by Manufacturers (2019-2024)
3.2 Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Group B Streptococcus (GBS) Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Group B Streptococcus (GBS) Infection Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Group B Streptococcus (GBS) Infection Treatment Sales Sites, Area Served, Product Type
3.6 Group B Streptococcus (GBS) Infection Treatment Market Competitive Situation and Trends
3.6.1 Group B Streptococcus (GBS) Infection Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Group B Streptococcus (GBS) Infection Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Group B Streptococcus (GBS) Infection Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Type (2019-2024)
6.3 Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Group B Streptococcus (GBS) Infection Treatment Price by Type (2019-2024)
7 GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Group B Streptococcus (GBS) Infection Treatment Market Sales by Application (2019-2024)
7.3 Global Group B Streptococcus (GBS) Infection Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Group B Streptococcus (GBS) Infection Treatment Sales Growth Rate by Application (2019-2024)
8 GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET SEGMENTATION BY REGION
8.1 Global Group B Streptococcus (GBS) Infection Treatment Sales by Region
8.1.1 Global Group B Streptococcus (GBS) Infection Treatment Sales by Region
8.1.2 Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Group B Streptococcus (GBS) Infection Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Group B Streptococcus (GBS) Infection Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Group B Streptococcus (GBS) Infection Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Group B Streptococcus (GBS) Infection Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Group B Streptococcus (GBS) Infection Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer Inc.
9.1.1 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Basic Information
9.1.2 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Product Overview
9.1.3 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Product Market Performance
9.1.4 Pfizer Inc. Business Overview
9.1.5 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment SWOT Analysis
9.1.6 Pfizer Inc. Recent Developments
9.2 Alopexx Enterprises, LLC
9.2.1 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Basic Information
9.2.2 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Product Overview
9.2.3 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Product Market Performance
9.2.4 Alopexx Enterprises, LLC Business Overview
9.2.5 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment SWOT Analysis
9.2.6 Alopexx Enterprises, LLC Recent Developments
9.3 Wellstat Vaccines LLC
9.3.1 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Basic Information
9.3.2 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Product Overview
9.3.3 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Product Market Performance
9.3.4 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment SWOT Analysis
9.3.5 Wellstat Vaccines LLC Business Overview
9.3.6 Wellstat Vaccines LLC Recent Developments
9.4 Minervax ApS
9.4.1 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Basic Information
9.4.2 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Product Overview
9.4.3 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Product Market Performance
9.4.4 Minervax ApS Business Overview
9.4.5 Minervax ApS Recent Developments
9.5 Novartis
9.5.1 Novartis Group B Streptococcus (GBS) Infection Treatment Basic Information
9.5.2 Novartis Group B Streptococcus (GBS) Infection Treatment Product Overview
9.5.3 Novartis Group B Streptococcus (GBS) Infection Treatment Product Market Performance
9.5.4 Novartis Business Overview
9.5.5 Novartis Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Basic Information
9.6.2 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Product Overview
9.6.3 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Product Market Performance
9.6.4 GlaxoSmithKline Business Overview
9.6.5 GlaxoSmithKline Recent Developments
10 GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET FORECAST BY REGION
10.1 Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast
10.2 Global Group B Streptococcus (GBS) Infection Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Region
10.2.4 South America Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Group B Streptococcus (GBS) Infection Treatment by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Group B Streptococcus (GBS) Infection Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Group B Streptococcus (GBS) Infection Treatment by Type (2025-2030)
11.1.2 Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Group B Streptococcus (GBS) Infection Treatment by Type (2025-2030)
11.2 Global Group B Streptococcus (GBS) Infection Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Group B Streptococcus (GBS) Infection Treatment Sales (K Units) Forecast by Application
11.2.2 Global Group B Streptococcus (GBS) Infection Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Group B Streptococcus (GBS) Infection Treatment
1.2 Key Market Segments
1.2.1 Group B Streptococcus (GBS) Infection Treatment Segment by Type
1.2.2 Group B Streptococcus (GBS) Infection Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Group B Streptococcus (GBS) Infection Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Group B Streptococcus (GBS) Infection Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Group B Streptococcus (GBS) Infection Treatment Sales by Manufacturers (2019-2024)
3.2 Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Group B Streptococcus (GBS) Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Group B Streptococcus (GBS) Infection Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Group B Streptococcus (GBS) Infection Treatment Sales Sites, Area Served, Product Type
3.6 Group B Streptococcus (GBS) Infection Treatment Market Competitive Situation and Trends
3.6.1 Group B Streptococcus (GBS) Infection Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Group B Streptococcus (GBS) Infection Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Group B Streptococcus (GBS) Infection Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Type (2019-2024)
6.3 Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Group B Streptococcus (GBS) Infection Treatment Price by Type (2019-2024)
7 GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Group B Streptococcus (GBS) Infection Treatment Market Sales by Application (2019-2024)
7.3 Global Group B Streptococcus (GBS) Infection Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Group B Streptococcus (GBS) Infection Treatment Sales Growth Rate by Application (2019-2024)
8 GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET SEGMENTATION BY REGION
8.1 Global Group B Streptococcus (GBS) Infection Treatment Sales by Region
8.1.1 Global Group B Streptococcus (GBS) Infection Treatment Sales by Region
8.1.2 Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Group B Streptococcus (GBS) Infection Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Group B Streptococcus (GBS) Infection Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Group B Streptococcus (GBS) Infection Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Group B Streptococcus (GBS) Infection Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Group B Streptococcus (GBS) Infection Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer Inc.
9.1.1 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Basic Information
9.1.2 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Product Overview
9.1.3 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Product Market Performance
9.1.4 Pfizer Inc. Business Overview
9.1.5 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment SWOT Analysis
9.1.6 Pfizer Inc. Recent Developments
9.2 Alopexx Enterprises, LLC
9.2.1 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Basic Information
9.2.2 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Product Overview
9.2.3 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Product Market Performance
9.2.4 Alopexx Enterprises, LLC Business Overview
9.2.5 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment SWOT Analysis
9.2.6 Alopexx Enterprises, LLC Recent Developments
9.3 Wellstat Vaccines LLC
9.3.1 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Basic Information
9.3.2 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Product Overview
9.3.3 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Product Market Performance
9.3.4 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment SWOT Analysis
9.3.5 Wellstat Vaccines LLC Business Overview
9.3.6 Wellstat Vaccines LLC Recent Developments
9.4 Minervax ApS
9.4.1 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Basic Information
9.4.2 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Product Overview
9.4.3 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Product Market Performance
9.4.4 Minervax ApS Business Overview
9.4.5 Minervax ApS Recent Developments
9.5 Novartis
9.5.1 Novartis Group B Streptococcus (GBS) Infection Treatment Basic Information
9.5.2 Novartis Group B Streptococcus (GBS) Infection Treatment Product Overview
9.5.3 Novartis Group B Streptococcus (GBS) Infection Treatment Product Market Performance
9.5.4 Novartis Business Overview
9.5.5 Novartis Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Basic Information
9.6.2 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Product Overview
9.6.3 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Product Market Performance
9.6.4 GlaxoSmithKline Business Overview
9.6.5 GlaxoSmithKline Recent Developments
10 GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET FORECAST BY REGION
10.1 Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast
10.2 Global Group B Streptococcus (GBS) Infection Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Region
10.2.4 South America Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Group B Streptococcus (GBS) Infection Treatment by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Group B Streptococcus (GBS) Infection Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Group B Streptococcus (GBS) Infection Treatment by Type (2025-2030)
11.1.2 Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Group B Streptococcus (GBS) Infection Treatment by Type (2025-2030)
11.2 Global Group B Streptococcus (GBS) Infection Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Group B Streptococcus (GBS) Infection Treatment Sales (K Units) Forecast by Application
11.2.2 Global Group B Streptococcus (GBS) Infection Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Group B Streptococcus (GBS) Infection Treatment Market Size Comparison by Region (M USD)
Table 5. Global Group B Streptococcus (GBS) Infection Treatment Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Group B Streptococcus (GBS) Infection Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Group B Streptococcus (GBS) Infection Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Group B Streptococcus (GBS) Infection Treatment as of 2022)
Table 10. Global Market Group B Streptococcus (GBS) Infection Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Group B Streptococcus (GBS) Infection Treatment Sales Sites and Area Served
Table 12. Manufacturers Group B Streptococcus (GBS) Infection Treatment Product Type
Table 13. Global Group B Streptococcus (GBS) Infection Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Group B Streptococcus (GBS) Infection Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Group B Streptococcus (GBS) Infection Treatment Market Challenges
Table 22. Global Group B Streptococcus (GBS) Infection Treatment Sales by Type (K Units)
Table 23. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Type (M USD)
Table 24. Global Group B Streptococcus (GBS) Infection Treatment Sales (K Units) by Type (2019-2024)
Table 25. Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Group B Streptococcus (GBS) Infection Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Group B Streptococcus (GBS) Infection Treatment Market Size Share by Type (2019-2024)
Table 28. Global Group B Streptococcus (GBS) Infection Treatment Price (USD/Unit) by Type (2019-2024)
Table 29. Global Group B Streptococcus (GBS) Infection Treatment Sales (K Units) by Application
Table 30. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Application
Table 31. Global Group B Streptococcus (GBS) Infection Treatment Sales by Application (2019-2024) & (K Units)
Table 32. Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Group B Streptococcus (GBS) Infection Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Application (2019-2024)
Table 35. Global Group B Streptococcus (GBS) Infection Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Group B Streptococcus (GBS) Infection Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Group B Streptococcus (GBS) Infection Treatment Sales by Country (2019-2024) & (K Units)
Table 39. Europe Group B Streptococcus (GBS) Infection Treatment Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Group B Streptococcus (GBS) Infection Treatment Sales by Region (2019-2024) & (K Units)
Table 41. South America Group B Streptococcus (GBS) Infection Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Group B Streptococcus (GBS) Infection Treatment Sales by Region (2019-2024) & (K Units)
Table 43. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Basic Information
Table 44. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Product Overview
Table 45. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Pfizer Inc. Business Overview
Table 47. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment SWOT Analysis
Table 48. Pfizer Inc. Recent Developments
Table 49. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Basic Information
Table 50. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Product Overview
Table 51. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Alopexx Enterprises, LLC Business Overview
Table 53. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment SWOT Analysis
Table 54. Alopexx Enterprises, LLC Recent Developments
Table 55. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Basic Information
Table 56. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Product Overview
Table 57. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment SWOT Analysis
Table 59. Wellstat Vaccines LLC Business Overview
Table 60. Wellstat Vaccines LLC Recent Developments
Table 61. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Basic Information
Table 62. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Product Overview
Table 63. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Minervax ApS Business Overview
Table 65. Minervax ApS Recent Developments
Table 66. Novartis Group B Streptococcus (GBS) Infection Treatment Basic Information
Table 67. Novartis Group B Streptococcus (GBS) Infection Treatment Product Overview
Table 68. Novartis Group B Streptococcus (GBS) Infection Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Novartis Business Overview
Table 70. Novartis Recent Developments
Table 71. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Basic Information
Table 72. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Product Overview
Table 73. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Recent Developments
Table 76. Global Group B Streptococcus (GBS) Infection Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 77. Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 78. North America Group B Streptococcus (GBS) Infection Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 79. North America Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 80. Europe Group B Streptococcus (GBS) Infection Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 81. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 82. Asia Pacific Group B Streptococcus (GBS) Infection Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 83. Asia Pacific Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 84. South America Group B Streptococcus (GBS) Infection Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 85. South America Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 86. Middle East and Africa Group B Streptococcus (GBS) Infection Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 87. Middle East and Africa Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Global Group B Streptococcus (GBS) Infection Treatment Sales Forecast by Type (2025-2030) & (K Units)
Table 89. Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 90. Global Group B Streptococcus (GBS) Infection Treatment Price Forecast by Type (2025-2030) & (USD/Unit)
Table 91. Global Group B Streptococcus (GBS) Infection Treatment Sales (K Units) Forecast by Application (2025-2030)
Table 92. Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Group B Streptococcus (GBS) Infection Treatment Market Size Comparison by Region (M USD)
Table 5. Global Group B Streptococcus (GBS) Infection Treatment Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Group B Streptococcus (GBS) Infection Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Group B Streptococcus (GBS) Infection Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Group B Streptococcus (GBS) Infection Treatment as of 2022)
Table 10. Global Market Group B Streptococcus (GBS) Infection Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Group B Streptococcus (GBS) Infection Treatment Sales Sites and Area Served
Table 12. Manufacturers Group B Streptococcus (GBS) Infection Treatment Product Type
Table 13. Global Group B Streptococcus (GBS) Infection Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Group B Streptococcus (GBS) Infection Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Group B Streptococcus (GBS) Infection Treatment Market Challenges
Table 22. Global Group B Streptococcus (GBS) Infection Treatment Sales by Type (K Units)
Table 23. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Type (M USD)
Table 24. Global Group B Streptococcus (GBS) Infection Treatment Sales (K Units) by Type (2019-2024)
Table 25. Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Group B Streptococcus (GBS) Infection Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Group B Streptococcus (GBS) Infection Treatment Market Size Share by Type (2019-2024)
Table 28. Global Group B Streptococcus (GBS) Infection Treatment Price (USD/Unit) by Type (2019-2024)
Table 29. Global Group B Streptococcus (GBS) Infection Treatment Sales (K Units) by Application
Table 30. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Application
Table 31. Global Group B Streptococcus (GBS) Infection Treatment Sales by Application (2019-2024) & (K Units)
Table 32. Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Group B Streptococcus (GBS) Infection Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Application (2019-2024)
Table 35. Global Group B Streptococcus (GBS) Infection Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Group B Streptococcus (GBS) Infection Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Group B Streptococcus (GBS) Infection Treatment Sales by Country (2019-2024) & (K Units)
Table 39. Europe Group B Streptococcus (GBS) Infection Treatment Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Group B Streptococcus (GBS) Infection Treatment Sales by Region (2019-2024) & (K Units)
Table 41. South America Group B Streptococcus (GBS) Infection Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Group B Streptococcus (GBS) Infection Treatment Sales by Region (2019-2024) & (K Units)
Table 43. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Basic Information
Table 44. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Product Overview
Table 45. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Pfizer Inc. Business Overview
Table 47. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment SWOT Analysis
Table 48. Pfizer Inc. Recent Developments
Table 49. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Basic Information
Table 50. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Product Overview
Table 51. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Alopexx Enterprises, LLC Business Overview
Table 53. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment SWOT Analysis
Table 54. Alopexx Enterprises, LLC Recent Developments
Table 55. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Basic Information
Table 56. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Product Overview
Table 57. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment SWOT Analysis
Table 59. Wellstat Vaccines LLC Business Overview
Table 60. Wellstat Vaccines LLC Recent Developments
Table 61. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Basic Information
Table 62. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Product Overview
Table 63. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Minervax ApS Business Overview
Table 65. Minervax ApS Recent Developments
Table 66. Novartis Group B Streptococcus (GBS) Infection Treatment Basic Information
Table 67. Novartis Group B Streptococcus (GBS) Infection Treatment Product Overview
Table 68. Novartis Group B Streptococcus (GBS) Infection Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Novartis Business Overview
Table 70. Novartis Recent Developments
Table 71. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Basic Information
Table 72. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Product Overview
Table 73. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Recent Developments
Table 76. Global Group B Streptococcus (GBS) Infection Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 77. Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 78. North America Group B Streptococcus (GBS) Infection Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 79. North America Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 80. Europe Group B Streptococcus (GBS) Infection Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 81. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 82. Asia Pacific Group B Streptococcus (GBS) Infection Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 83. Asia Pacific Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 84. South America Group B Streptococcus (GBS) Infection Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 85. South America Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 86. Middle East and Africa Group B Streptococcus (GBS) Infection Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 87. Middle East and Africa Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Global Group B Streptococcus (GBS) Infection Treatment Sales Forecast by Type (2025-2030) & (K Units)
Table 89. Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 90. Global Group B Streptococcus (GBS) Infection Treatment Price Forecast by Type (2025-2030) & (USD/Unit)
Table 91. Global Group B Streptococcus (GBS) Infection Treatment Sales (K Units) Forecast by Application (2025-2030)
Table 92. Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Group B Streptococcus (GBS) Infection Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Group B Streptococcus (GBS) Infection Treatment Market Size (M USD), 2019-2030
Figure 5. Global Group B Streptococcus (GBS) Infection Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Group B Streptococcus (GBS) Infection Treatment Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Group B Streptococcus (GBS) Infection Treatment Market Size by Country (M USD)
Figure 11. Group B Streptococcus (GBS) Infection Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Group B Streptococcus (GBS) Infection Treatment Revenue Share by Manufacturers in 2023
Figure 13. Group B Streptococcus (GBS) Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Group B Streptococcus (GBS) Infection Treatment Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Group B Streptococcus (GBS) Infection Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Type
Figure 18. Sales Market Share of Group B Streptococcus (GBS) Infection Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Group B Streptococcus (GBS) Infection Treatment by Type in 2023
Figure 20. Market Size Share of Group B Streptococcus (GBS) Infection Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Group B Streptococcus (GBS) Infection Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Application
Figure 24. Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Application in 2023
Figure 26. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Application (2019-2024)
Figure 27. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Application in 2023
Figure 28. Global Group B Streptococcus (GBS) Infection Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Group B Streptococcus (GBS) Infection Treatment Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Group B Streptococcus (GBS) Infection Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Country in 2023
Figure 37. Germany Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Region in 2023
Figure 44. China Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (K Units)
Figure 50. South America Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Group B Streptococcus (GBS) Infection Treatment Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Group B Streptococcus (GBS) Infection Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Group B Streptococcus (GBS) Infection Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Group B Streptococcus (GBS) Infection Treatment Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Group B Streptococcus (GBS) Infection Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Group B Streptococcus (GBS) Infection Treatment Market Size (M USD), 2019-2030
Figure 5. Global Group B Streptococcus (GBS) Infection Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Group B Streptococcus (GBS) Infection Treatment Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Group B Streptococcus (GBS) Infection Treatment Market Size by Country (M USD)
Figure 11. Group B Streptococcus (GBS) Infection Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Group B Streptococcus (GBS) Infection Treatment Revenue Share by Manufacturers in 2023
Figure 13. Group B Streptococcus (GBS) Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Group B Streptococcus (GBS) Infection Treatment Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Group B Streptococcus (GBS) Infection Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Type
Figure 18. Sales Market Share of Group B Streptococcus (GBS) Infection Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Group B Streptococcus (GBS) Infection Treatment by Type in 2023
Figure 20. Market Size Share of Group B Streptococcus (GBS) Infection Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Group B Streptococcus (GBS) Infection Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Application
Figure 24. Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Application in 2023
Figure 26. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Application (2019-2024)
Figure 27. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Application in 2023
Figure 28. Global Group B Streptococcus (GBS) Infection Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Group B Streptococcus (GBS) Infection Treatment Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Group B Streptococcus (GBS) Infection Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Country in 2023
Figure 37. Germany Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Region in 2023
Figure 44. China Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (K Units)
Figure 50. South America Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Group B Streptococcus (GBS) Infection Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Group B Streptococcus (GBS) Infection Treatment Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Group B Streptococcus (GBS) Infection Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Group B Streptococcus (GBS) Infection Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Group B Streptococcus (GBS) Infection Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Group B Streptococcus (GBS) Infection Treatment Market Share Forecast by Application (2025-2030)
